IN2014DN07896A - - Google Patents
Info
- Publication number
- IN2014DN07896A IN2014DN07896A IN7896DEN2014A IN2014DN07896A IN 2014DN07896 A IN2014DN07896 A IN 2014DN07896A IN 7896DEN2014 A IN7896DEN2014 A IN 7896DEN2014A IN 2014DN07896 A IN2014DN07896 A IN 2014DN07896A
- Authority
- IN
- India
- Prior art keywords
- relates
- gelling agents
- composition
- adapalene
- carbomer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a stable topical aqueous composition of adapalene in combination with benzoyl peroxide comprising one or more gelling agents, wherein at least one of the gelling agents is a carbomer. It also relates to processes for preparing such composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN7896DEN2014 IN2014DN07896A (en) | 2012-02-21 | 2013-02-21 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2013/051434 WO2013124820A1 (en) | 2012-02-21 | 2013-02-21 | Composition comprising a retinoid and benzoyl peroxide |
IN497DE2012 IN2012DE00497A (en) | 2012-02-21 | 2013-02-21 | |
IN7896DEN2014 IN2014DN07896A (en) | 2012-02-21 | 2013-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN07896A true IN2014DN07896A (en) | 2015-04-24 |
Family
ID=48142029
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN7896DEN2014 IN2014DN07896A (en) | 2012-02-21 | 2013-02-21 | |
IN497DE2012 IN2012DE00497A (en) | 2012-02-21 | 2013-02-21 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN497DE2012 IN2012DE00497A (en) | 2012-02-21 | 2013-02-21 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2817069A1 (en) |
BR (1) | BR112014020545A2 (en) |
IN (2) | IN2014DN07896A (en) |
WO (1) | WO2013124820A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018073751A1 (en) * | 2016-10-17 | 2018-04-26 | Sun Pharmaceutical Industries Limited | Method of treating acne |
CN114788791A (en) | 2017-06-23 | 2022-07-26 | 宝洁公司 | Compositions and methods for improving the appearance of skin |
TR201720497A2 (en) * | 2017-12-15 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | COMBINATION CONTAINING ADAPALENE, BENZOIL PEROXIDE AND AN AGENT FROM THE CICATRIZAN GROUP |
TR201720506A2 (en) * | 2017-12-15 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | The combination comprising adapalene and benzoyl peroxide |
CA3102288A1 (en) | 2018-07-03 | 2020-01-09 | The Procter & Gamble Company | Method of treating a skin condition |
EP4157206A1 (en) | 2020-06-01 | 2023-04-05 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4497794A (en) | 1980-12-08 | 1985-02-05 | Dermik Laboratories, Inc. | Erythromycin/benzoyl peroxide composition for the treatment of acne |
US4361584A (en) | 1977-10-07 | 1982-11-30 | A.H.C. Pharmacal, Inc. | Composition and method for the treatment of acne |
US4350681A (en) | 1977-10-07 | 1982-09-21 | A.H.C. Pharmacal, Inc. | Stabilized benzoyl peroxide compositions |
US4387107A (en) | 1979-07-25 | 1983-06-07 | Dermik Laboratories, Inc. | Stable benzoyl peroxide composition |
LU85111A1 (en) | 1983-12-01 | 1985-09-12 | Oreal | ANTI-ACNETIC COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE SOLAR FILTER |
US5086075A (en) | 1985-01-24 | 1992-02-04 | Board Of Regents, The University Of Texas System | Therapeutic compositions containing benzoyl peroxide |
US5446028A (en) | 1985-12-12 | 1995-08-29 | Dermik Laboratories, Inc. | Anti-acne method and composition |
US5879716A (en) | 1985-12-18 | 1999-03-09 | Advanced Polymer Systems, Inc. | Methods and compositions for topical delivery of benzoyl peroxide |
US5955109A (en) | 1985-12-18 | 1999-09-21 | Advanced Polymer Systems, Inc. | Methods and compositions for topical delivery of retinoic acid |
US5145675A (en) | 1986-03-31 | 1992-09-08 | Advanced Polymer Systems, Inc. | Two step method for preparation of controlled release formulations |
FR2628319B1 (en) | 1988-03-09 | 1990-12-07 | Oreal | PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON BENZOYL PEROXIDE AND QUATERNARY AMMONIUM SALTS |
US6117843A (en) | 1992-02-18 | 2000-09-12 | Lloyd J. Baroody | Compositions for the treatment of acne containing clindamycin and benzoyl peroxide |
US5466446A (en) | 1994-02-16 | 1995-11-14 | Stiefel Laboratories, Inc. | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
US5632996A (en) | 1995-04-14 | 1997-05-27 | Imaginative Research Associates, Inc. | Benzoyl peroxide and benzoate ester containing compositions suitable for contact with skin |
US5851538A (en) | 1995-12-29 | 1998-12-22 | Advanced Polymer Systems, Inc. | Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
US5998392A (en) | 1996-04-10 | 1999-12-07 | Gattefosse S.A. | Benzoyl peroxide flocculent materials and methods of their preparation |
US6013637A (en) | 1998-06-12 | 2000-01-11 | Dermik Laboratories Inc. | Anti-acne method and composition |
US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
IL161782A0 (en) | 2001-11-08 | 2005-11-20 | Sol Gel Technologies Ltd | Compositions containing oils havinga specific gravity higher than the specific gravity of water |
US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
FR2903604B1 (en) | 2006-07-13 | 2008-09-05 | Galderma Res & Dev S N C Snc | COMPOSITION COMPRISING A RETINOID AND BENZOYL PEROXIDE |
MXPA06008988A (en) * | 2006-08-08 | 2008-02-07 | Fernando Ahumada Ayala | Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide). |
FR2909000B1 (en) | 2006-11-28 | 2009-02-06 | Galderma Res & Dev S N C Snc | COMPOSITIONS COMPRISING BENZOYL PEROXIDE, AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE POLYURETHANE POLYMER COMPOUND OR DERIVATIVES THEREOF, AND USES THEREOF. |
FR2910321B1 (en) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
FR2910320B1 (en) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
EP1967180A1 (en) * | 2007-03-06 | 2008-09-10 | Almirall Hermal GmbH | Topical composition comprising a retinoid receptor agonist |
FR2926218B1 (en) | 2008-01-10 | 2010-08-13 | Galderma Res & Dev | COMPOSITION COMPRISING RETINOID AND DISPERSE BENZOYL PEROXIDE. |
-
2013
- 2013-02-21 IN IN7896DEN2014 patent/IN2014DN07896A/en unknown
- 2013-02-21 WO PCT/IB2013/051434 patent/WO2013124820A1/en active Application Filing
- 2013-02-21 BR BR112014020545A patent/BR112014020545A2/en not_active IP Right Cessation
- 2013-02-21 EP EP13717315.9A patent/EP2817069A1/en not_active Withdrawn
- 2013-02-21 IN IN497DE2012 patent/IN2012DE00497A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2817069A1 (en) | 2014-12-31 |
WO2013124820A1 (en) | 2013-08-29 |
BR112014020545A2 (en) | 2019-09-24 |
IN2012DE00497A (en) | 2015-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN07896A (en) | ||
PH12014502602A1 (en) | Methods for improving safety of blood-brain barrier transport | |
MX2015008627A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2016016666A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
PH12015500900B1 (en) | A stabilized pemetrexed formulation | |
MX2016015093A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX370903B (en) | Stable percarboxylic acid compositions and uses thereof. | |
MY170302A (en) | Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use | |
MX2014010323A (en) | Alkylated cyclodextrin compositions and processes for preparing and using the same. | |
MX2015002040A (en) | Deuterated baricitinib. | |
JO3241B1 (en) | Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use | |
PH12015500887B1 (en) | Alkylated cyclodextrin compositions and processes for preparing and using the same | |
IN2014DN06104A (en) | ||
PH12015502665A1 (en) | Improvements in or relating to organic compounds | |
TR201905787T4 (en) | Lyophilized TAT-NR2B9C formulation. | |
EA027567B9 (en) | Process for the preparation of a storage-stable beverage | |
TWD160320S (en) | Note dispenser | |
MX2015013535A (en) | FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca). | |
MX358132B (en) | Thrombin solution and methods of use thereof. | |
UA117567C2 (en) | Galactagogue compositions based on phosphatidylserine | |
MY175703A (en) | Tablets with improved acceptance and good storage stability | |
IN2014KN02683A (en) | ||
IN2015DN00962A (en) | ||
MX351093B (en) | Novel azetidine derivatives. | |
UA79866U (en) | use of derivatives of 2-oxoindoline-3-glyoxalic acid as agents with antidepressive action |